Clinical Trial Update: Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether perioperative glucocorticoid replacement improves prognosis after surgery for sellar lesions, including pituita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniopharyngioma
• Pituitary Neoplasms

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: West China Hospital | Conditions: Pituitary Neoplasms, Craniopharyngiomas | Phase 4 | Status: UNKNOWN